Princeton Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Princeton Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-2,818	Closed	-$232K	–	85
2014 Q2	$232K	Sell	2,818 -4,550	-62%	-$348K	0.2%	80
2014 Q1	$565K	Buy	7,368 +4,000	+119%	+$312K	0.48%	67
2013 Q4	$233K	Buy	+3,368	New	+$221K	0.19%	87

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Princeton Capital Management's FBT Position: Q3 2014 in Review

Princeton Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2014, closing a stake of 2,818 shares — an estimated $232K sold.

Princeton Capital Management first reported a position in FBT in Q4 2013 and held it in 3 quarters. The position peaked at $565K in Q1 2014. 98 funds tracked by Wall St. Rank hold FBT as of Q3 2014.

Princeton Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2014 after selling out during the quarter.
Princeton Capital Management sold 2,818 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2014, an estimated $232K.
Princeton Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2013 and held it in 3 quarters.
Princeton Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $565K in Q1 2014.
98 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2014.

Based on Princeton Capital Management's 13F filing for Q3 2014, filed 29 Oct 2014.